CD47 and neoplasm: Moreover, this nanovaccine can alleviate chemotherapy‐induced immunosuppression by augmenting the proportion of M1‐like TAMs, enhancing the infiltration of CD8+ T cells, and downregulating the expression of CD47 through the reduction of HIF1A in ID8 tumor cells.